𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regulation of angiogenesis and tumor growth by p110 Alpha and AKT1 via VEGF expression

✍ Scribed by Chang Xia; Qiao Meng; Zongxian Cao; Xianglin Shi; Bing-Hua Jiang


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
437 KB
Volume
209
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Recent studies demonstrate that PI3K activation and PTEN mutation are frequently found in many human cancer cells and tissues. However, the mechanism of PI3K signaling in human cancer tumorigenesis remains to be elucidated. In this study we specifically downregulated p110α expression in ovarian cancer cells using siRNA interference. We found that p110α downregulation greatly decreased ovarian tumor growth and angiogenesis, and that p110α siRNA inhibited VEGF expression through decreasing hypoxia‐inducible factor 1α expression in both ovarian cancer cells and tumor tissues. To determine the downstream targets of PI3K in regulating tumor growth and angiogenesis, we find that AKT1 is a major downstream mediator for regulating tumor growth, angiogenesis, and VEGF expression. These data show that p110α and AKT1 play an important role in tumor growth by inducing angiogenesis and by increasing HIF‐1α and VEGF expression. This work provides a better understanding of the molecular mechanism of human cancer induced by the activation of PI3K signaling. J. Cell. Physiol. 209: 56–66, 2006. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Differential expression of VEGF-A and an
✍ Thomas Kalinski; Sabine Krueger; Saadettin Sel; Kerstin Werner; Martin Ropke; Al 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

## Abstract ## BACKGROUND Vascular endothelial growth factor (VEGF)‐A and angiopoietin (Ang)‐1 and Ang‐2 are key factors in angiogenic signaling. In this study the expression of these factors was identified in cartilage tumors. As interleukin (IL)‐1β has been found to be an indispensable factor in

Inhibition of HIF-1 alpha and VEGF expre
✍ Salida Mirzoeva; Nam Deuk Kim; Karen Chiu; Carrie A. Franzen; Raymond C. Bergan; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

## Abstract Progression of cancer leads to hypoxic solid tumors that mount specific cell signaling responses to low oxygen conditions. An important objective of anti‐cancer therapy is the development of new drugs that suppress hypoxic responses in solid tumors. Apigenin is a natural flavone that ha

Suppression of tumor growth, invasion an
✍ Daniëlle A. M. Heideman; Victor W. van Beusechem; Elisabeth Bloemena; Peter J. F 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

## Abstract ## Background To improve the prognosis of patients with gastric cancer it is important to develop novel treatment modalities targeting the malignant behavior of tumor cells. Concerning this, NK4, which acts as HGF‐antagonist and angiogenesis inhibitor, might be a potential therapeutic

Induction of mdr1b mRNA and P-glycoprote
✍ Karen I. Hirsch-Ernst; Christina Ziemann; Heidi Foth; Detlef Kozian; Christoph S 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 2 views

Mammalian liver exhibits expression of members of the family of multidrug resistance (mdr) transporters (P-glycoproteins). P-glycoprotein isoforms encoded by mdr1 genes participate in extrusion of an array of xenobiotics into the bile. Induction of mdr1b mRNA expression has been shown to occur in ra

Suppression of EGF-induced tumor cell mi
✍ Yong Pil Hwang; Hyo Jeong Yun; Jae Ho Choi; Eun Hee Han; Hyung Gyun Kim; Gye Yon 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

## Abstract **Scope:** Capsaicin is a cancer‐suppressing agent. The aim of our study was to determine the effect of capsaicin on tumor invasion and migration; the possible mechanisms involved in this inhibition were investigated in human fibrosarcoma cells. **Methods and results:** We employed inv